Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Irritable Bowel Syndrome
Recent news which mentions Irritable Bowel Syndrome
Psilocybin For IBS Gets FDA Nod To Begin Clinical Trials At Mass. General Hospital
July 13, 2023
Tickers
TRYPF
Tags
Psychedelics
Cannabis
Market News
From
Benzinga
Therapists At Mass General Hospital Prepared To Assist IBS Patients With Psilocybin Therapy
April 04, 2023
Tickers
TRYPF
Tags
TRYPF
Psilocybin program
Benzinga
From
Benzinga
Can Marijuana Treat Autism, OCD & Irritable Bowel Syndrome? Ohio Medical Panel Will Investigate
February 13, 2023
Tickers
GCAN
Tags
Ohio Cannabis
Health Care
State Medical Board of Ohio
From
Benzinga
Business & Academia Join Forces To Study Magic Mushroom Therapy For IBS Patients
January 03, 2023
Tickers
TRYPF
Tags
Psychedelics
Benzinga
TRYPF
From
Benzinga
Silo Wellness To Acquire Canadian Dyscovry Science, Producer Of Psilocybin For IBS Treatment
May 31, 2022
Tickers
SILFF
Tags
General
M&A
News
From
Benzinga
Biomerica Posts Encouraging Results From InFoods Study As Irritable Bowel Syndrome Treatment
February 08, 2022
Tickers
BMRA
Tags
Market News
Irritable Bowel Syndrome
Penny Stocks
From
Benzinga
Citi, Ladenburg React Positively On Ardelyx's IBS-C Treatment Launch Plans
December 01, 2021
Tickers
ARDX
Tags
Briefs
News
Movers
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.